Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,290 INR | -0.12% | -0.98% | -4.91% |
24/05 | Caplin Point Arm Gets US FDA's Nod for Phenylephrine Hydrochloride Ophthalmic Solution | MT |
16/05 | Caplin Point Laboratories to Seek Acquisitions | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.91% | 117.35Cr | |
+15.91% | 4.2TCr | |
+22.40% | 2.23TCr | |
+18.48% | 1.52TCr | |
+16.12% | 1.4TCr | |
+45.12% | 1.21TCr | |
-9.58% | 679.6Cr | |
-0.05% | 678.76Cr | |
-8.87% | 572.55Cr | |
+14.18% | 549.33Cr |
- Stock Market
- Equities
- CAPLIPOINT Stock
- News Caplin Point Laboratories Limited
- Transcript : Caplin Point Laboratories Limited, Q4 2024 Earnings Call, May 16, 2024